Jazz Pharmaceuticals plc (65) | Uncategorized (12)

Recent Contracts

Amendment No (Filed With SEC on March 1, 2022)
Jazz Pharmaceuticals plc (Filed With SEC on March 1, 2022)
Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals PLC (Filed With SEC on February 4, 2021)
Offer Letter, dated as of May 2, 2020, by and between Jazz Pharmaceuticals, Inc. and Kim Sablich (Filed With SEC on August 4, 2020)
Offer Letter, dated as of February 23, 2020, by and between Jazz Pharmaceuticals, Inc. and Rene Gal (Filed With SEC on May 5, 2020)
Contract Manufacturing Agreement, dated as of January 20, 2020, by and between Jazz Pharmaceuticals Ireland Limited and Siegfried AG (Filed With SEC on February 25, 2020)
Compromise Agreement, dated as of October 5, 2019, by and between Jazz Pharmaceuticals Ireland Limited and Paul Treacy (Filed With SEC on February 25, 2020)
Equity Award Letter, dated as of December 9, 2019, by and between Jazz Pharmaceuticals UK Limited and Samantha Pearce (Filed With SEC on February 25, 2020)
Offer Letter, dated as of July 5, 2019 by and between Jazz Pharmaceuticals, Inc. and Neena M. Patil (Filed With SEC on November 5, 2019)
Offer Letter from Jazz Pharmaceuticals, Inc. to Robert Iannone dated as of April 11, 2019 (Filed With SEC on August 6, 2019)
Letter Agreement, dated as of June 10, 2019, by and between Jazz Pharmaceuticals, Inc. and Suzanne Sawochka Hooper (Filed With SEC on August 6, 2019)
Contract Variation Agreement by and between Porton Biopharma Limited and Jazz Pharmaceuticals France SAS, dated as of December 20, 2018 (Filed With SEC on February 26, 2019)